Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Recruiting 9Not yet recruiting 5Active not recruiting 3Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 3Neoplasms 2Fallopian Tube Neoplasms 2Stomach Neoplasms 1Ovarian Neoplasms 1Microsatellite Instability 1Lymphedema 1Lung Neoplasms 1Hematopoietic Cell Transplantation Recipient 1Gastritis, Atrophic 1Endometrial Neoplasms 1Depression 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Cancer Awareness and Prevention Education 1Brenner Tumor 1Breast Carcinoma In Situ 1Anxiety Disorders 1

Interventions

Cisplatin 38Carboplatin 28Gemcitabine 23Docetaxel 20Radiotherapy 18Etoposide 15Paclitaxel 13Erlotinib Hydrochloride 13Vinorelbine 11Drug Therapy 11pembrolizumab 9aumolertinib 9apatinib 9Pemetrexed 9Gefitinib 9osimertinib 7endostar protein 7Thoracic Surgery, Video-Assisted 7Blood Specimen Collection 7camrelizumab 6anlotinib 6Vinblastine 6Surgical Procedures, Operative 6sintilimab 5Radiosurgery 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5durvalumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lung Neoplasms × Educational Status × Clear all
NCT05078918 2022-11-21

Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors

Samsung Medical Center

Phase NA Unknown
800 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡